Logo image of SPNT

SIRIUSPOINT LTD (SPNT) Stock Fundamental Analysis

NYSE:SPNT - New York Stock Exchange, Inc. - BMG8192H1060 - Common Stock - Currency: USD

16.54  -0.06 (-0.36%)

After market: 16.54 0 (0%)

Fundamental Rating

4

Taking everything into account, SPNT scores 4 out of 10 in our fundamental rating. SPNT was compared to 143 industry peers in the Insurance industry. There are concerns on the financial health of SPNT while its profitability can be described as average. SPNT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SPNT had positive earnings in the past year.
In the past year SPNT had a positive cash flow from operations.
Of the past 5 years SPNT 4 years were profitable.
Each year in the past 5 years SPNT had a positive operating cash flow.
SPNT Yearly Net Income VS EBIT VS OCF VS FCFSPNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.39%, SPNT is in line with its industry, outperforming 43.36% of the companies in the same industry.
SPNT has a Return On Equity (8.98%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 3.55%, SPNT is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
ROA 1.39%
ROE 8.98%
ROIC 3.55%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
SPNT Yearly ROA, ROE, ROICSPNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

SPNT has a Profit Margin (6.25%) which is comparable to the rest of the industry.
SPNT's Profit Margin has declined in the last couple of years.
SPNT's Operating Margin of 18.01% is fine compared to the rest of the industry. SPNT outperforms 72.73% of its industry peers.
In the last couple of years the Operating Margin of SPNT has declined.
Industry RankSector Rank
OM 18.01%
PM (TTM) 6.25%
GM N/A
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
SPNT Yearly Profit, Operating, Gross MarginsSPNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SPNT is destroying value.
The number of shares outstanding for SPNT has been reduced compared to 1 year ago.
The number of shares outstanding for SPNT has been increased compared to 5 years ago.
SPNT has a better debt/assets ratio than last year.
SPNT Yearly Shares OutstandingSPNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SPNT Yearly Total Debt VS Total AssetsSPNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

SPNT has a debt to FCF ratio of 8.56. This is a slightly negative value and a sign of low solvency as SPNT would need 8.56 years to pay back of all of its debts.
The Debt to FCF ratio of SPNT (8.56) is worse than 72.73% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that SPNT is not too dependend on debt financing.
The Debt to Equity ratio of SPNT (0.33) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 8.56
Altman-Z N/A
ROIC/WACC0.41
WACC8.69%
SPNT Yearly LT Debt VS Equity VS FCFSPNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SPNT Yearly Current Assets VS Current LiabilitesSPNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

SPNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.27%.
The earnings per share for SPNT have been decreasing by -14.97% on average. This is quite bad
SPNT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.71%.
Measured over the past years, SPNT shows a very strong growth in Revenue. The Revenue has been growing by 22.87% on average per year.
EPS 1Y (TTM)-51.27%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%-126%
Revenue 1Y (TTM)1.71%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%-5.11%

3.2 Future

Based on estimates for the next years, SPNT will show a very strong growth in Earnings Per Share. The EPS will grow by 42.09% on average per year.
The Revenue is expected to grow by 1.28% on average over the next years.
EPS Next Y112.5%
EPS Next 2Y57.17%
EPS Next 3Y42.09%
EPS Next 5YN/A
Revenue Next Year-6.48%
Revenue Next 2Y-0.53%
Revenue Next 3Y1.28%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SPNT Yearly Revenue VS EstimatesSPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
SPNT Yearly EPS VS EstimatesSPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.23, which indicates a rather expensive current valuation of SPNT.
62.94% of the companies in the same industry are cheaper than SPNT, based on the Price/Earnings ratio.
SPNT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.78.
With a Price/Forward Earnings ratio of 8.11, the valuation of SPNT can be described as very reasonable.
Based on the Price/Forward Earnings ratio, SPNT is valued a bit cheaper than the industry average as 69.93% of the companies are valued more expensively.
SPNT is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.23
Fwd PE 8.11
SPNT Price Earnings VS Forward Price EarningsSPNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SPNT is valued cheaply inside the industry as 82.52% of the companies are valued more expensively.
64.34% of the companies in the same industry are cheaper than SPNT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 23.53
EV/EBITDA 3.34
SPNT Per share dataSPNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SPNT's earnings are expected to grow with 42.09% in the coming years.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y57.17%
EPS Next 3Y42.09%

0

5. Dividend

5.1 Amount

SPNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SIRIUSPOINT LTD

NYSE:SPNT (4/25/2025, 8:04:01 PM)

After market: 16.54 0 (0%)

16.54

-0.06 (-0.36%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)05-05 2025-05-05
Inst Owners89.4%
Inst Owner Change-59.39%
Ins Owners1.32%
Ins Owner Change-1.1%
Market Cap1.76B
Analysts85.71
Price Target17.34 (4.84%)
Short Float %2.29%
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP9.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-86.52%
Min EPS beat(2)-131.86%
Max EPS beat(2)-41.18%
EPS beat(4)2
Avg EPS beat(4)-24.02%
Min EPS beat(4)-131.86%
Max EPS beat(4)39.71%
EPS beat(8)6
Avg EPS beat(8)56.69%
EPS beat(12)6
Avg EPS beat(12)-13.58%
EPS beat(16)10
Avg EPS beat(16)12.09%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)15%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)11.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.23
Fwd PE 8.11
P/S 0.63
P/FCF 23.53
P/OCF 23.53
P/B 0.91
P/tB 0.98
EV/EBITDA 3.34
EPS(TTM)0.96
EY5.8%
EPS(NY)2.04
Fwd EY12.33%
FCF(TTM)0.7
FCFY4.25%
OCF(TTM)0.7
OCFY4.25%
SpS26.2
BVpS18.23
TBVpS16.91
PEG (NY)0.15
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.39%
ROE 8.98%
ROCE 4.09%
ROIC 3.55%
ROICexc 3.76%
ROICexgc 5.21%
OM 18.01%
PM (TTM) 6.25%
GM N/A
FCFM 2.68%
ROA(3y)0.13%
ROA(5y)0.97%
ROE(3y)1.05%
ROE(5y)2.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-10.36%
ROICexc growth 3YN/A
ROICexc growth 5Y-11.48%
OM growth 3YN/A
OM growth 5Y-4.18%
PM growth 3Y45.15%
PM growth 5Y-20.65%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 8.56
Debt/EBITDA 1.25
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 7.55
Cash Conversion 14.56%
Profit Quality 42.93%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.69%
ROIC/WACC0.41
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.27%
EPS 3Y-21.17%
EPS 5Y-14.97%
EPS Q2Q%-126%
EPS Next Y112.5%
EPS Next 2Y57.17%
EPS Next 3Y42.09%
EPS Next 5YN/A
Revenue 1Y (TTM)1.71%
Revenue growth 3Y8.91%
Revenue growth 5Y22.87%
Sales Q2Q%-5.11%
Revenue Next Year-6.48%
Revenue Next 2Y-0.53%
Revenue Next 3Y1.28%
Revenue Next 5YN/A
EBIT growth 1Y18.88%
EBIT growth 3YN/A
EBIT growth 5Y17.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-87.15%
FCF growth 3Y260.08%
FCF growth 5Y-11.94%
OCF growth 1Y-87.15%
OCF growth 3Y260.08%
OCF growth 5Y-11.94%